- $11.98bn
- $42.83bn
- $12.67bn
- 57
- 63
- 83
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,189 | 9,660 | 11,141 | 12,617 | 12,668 |
Cost of Revenue | |||||
Gross Profit | 2,349 | 2,693 | 2,711 | 2,548 | 2,504 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,297 | 8,255 | 11,582 | 11,806 | 11,437 |
Operating Profit | 1,892 | 1,405 | -441 | 811 | 1,231 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,001 | 488 | -1,064 | -169 | 104 |
Provision for Income Taxes | |||||
Net Income After Taxes | 649 | 272 | -931 | -434 | -157 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 303 | 46 | -409 | -546 | 249 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 303 | 46 | -409 | -546 | 250 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.711 | 1.04 | 2.41 | 0.712 | 1.23 |
Dividends per Share |